{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:11:51Z","timestamp":1762935111188,"version":"3.45.0"},"reference-count":47,"publisher":"PAGEPress Publications","issue":"3","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Monaldi Arch Chest Dis"],"abstract":"<jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense RNA virus. The SARS-CoV-2 virus is evolving continuously, and many variants have been detected over the last few years. SARS-CoV-2, as an RNA virus, is more prone to mutating. The continuous evolution of the SARS-CoV-2 virus is due to genetic mutation and recombination during the genomic replication process. Recombination is a naturally occurring phenomenon in which two distinct viral lineages simultaneously infect the same cellular entity in an individual. The evolution rate depends on the rate of mutation. The rate of mutation is variable among the RNA viruses, with the SARS-CoV-2 virus exhibiting a lower rate of mutation than other RNA viruses. The novel 3\u2032-to-5\u2032 exoribonuclease proofreading machinery is responsible for a lower rate of mutation. Infections due to SARS-CoV-2, influenza, and respiratory syncytial virus have been reported from around the world during the same period of fall and winter, resulting in a \u201ctripledemic\u201d. The JN.1 variant, which evolved from the predecessor, the Omicron variant BA.2.86, is currently the most dominant globally. The impact of the JN.1 variant on transmissibility, disease severity, immune evasion, and diagnostic and therapeutic escape will be discussed.<\/jats:p>","DOI":"10.4081\/monaldi.2024.2981","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T10:14:31Z","timestamp":1725012871000},"source":"Crossref","is-referenced-by-count":2,"title":["SARS-CoV-2 JN.1 variant: a short review"],"prefix":"10.4081","volume":"95","author":[{"given":"Sarkar","family":"Malay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irappa V.","family":"Madabhavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"43796","unstructured":"CDC. SARS-CoV-2 variant classifications and definitions. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/105817"},{"key":"43797","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2299-6"},{"key":"43798","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00878-2"},{"key":"43799","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05644-7"},{"key":"43800","unstructured":"Tamura T, Irie T, Deguchi S, et al. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant. Nat Commun. 2024 Feb 8;15(1):1176."},{"key":"43801","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.03.027"},{"key":"43802","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165878"},{"key":"43803","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104831"},{"key":"43804","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01712-0"},{"key":"43805","unstructured":"WHO. Tracking SARS-CoV-2 variants. Available from: https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants. Accessed on: 5\/03\/2024."},{"key":"43806","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-02656-9"},{"key":"43807","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00573-X"},{"key":"43808","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06750-w"},{"key":"43809","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00745-22"},{"key":"43810","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.12.025"},{"key":"43811","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714385114"},{"key":"43812","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.12.026"},{"key":"43813","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00575-3"},{"key":"43814","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01066-7"},{"key":"43815","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.09.003"},{"key":"43816","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1900"},{"key":"43817","doi-asserted-by":"publisher","DOI":"10.3390\/v16010003"},{"key":"43818","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00744-2"},{"key":"43819","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00813-7"},{"key":"43820","unstructured":"CDC. Update on SARS-CoV-2 variant JN.1 being tracked by CDC. Available from: https:\/\/www.cdc.gov\/ncird\/whats-new\/SARS-CoV-2-variant-JN.1.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Frespiratory-viruses%2Fwhats-new%2FSARS-CoV-2-variant-JN.1.html. Accessed on: 2\/03\/2024."},{"key":"43821","unstructured":"The Conversation. The emergence of JN.1 is an evolutionary \u2018step change\u2019 in the COVID pandemic. Why is this significant?. Available from: https:\/\/theconversation.com\/the-emergence-of-jn-1-is-an-evolutionary-step-change-in-the-covid-pandemic-why-is-this-significant-220285. Accessed on: 2\/03\/2024."},{"key":"43822","unstructured":"WHO. COVID-19 epidemiological update \u2013 22 December 2023. Available from: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update---22-december-2023. Accessed on: 26\/12\/2023."},{"key":"43823","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p2975"},{"key":"43824","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46490-7"},{"key":"43825","doi-asserted-by":"publisher","DOI":"10.3390\/v16010102"},{"key":"43826","unstructured":"CDC. Summary of variant surveillance. Available from: https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-summary. Accessed on: 26\/12\/2023."},{"key":"43827","unstructured":"Stanford Univeristy. Omicron XBB. Available from: https:\/\/covdb.stanford.edu\/variants\/omicron_xbb\/. Accessed on: 26\/12\/2023."},{"key":"43828","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.01.003"},{"key":"43829","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23029"},{"key":"43830","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.752003"},{"key":"43831","unstructured":"WHO. Statement on the antigen composition of COVID-19 vaccines. Available from: https:\/\/www.who.int\/news\/item\/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines"},{"key":"43832","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2024-0010"},{"key":"43833","unstructured":"IDSA. Will COVID vaccines continue to work against JN.1 and other new variants?. Available from: https:\/\/www.idsociety.org\/covid-19-real-time-learning-network\/vaccines\/will-covid-vaccines-continue-to-work-against-jn.1-and-other-new-variants#\/+\/0\/publishedDate_na_dt\/desc\/. Accessed on: 26\/12\/2023."},{"key":"43834","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.27841"},{"key":"43835","unstructured":"WHO. Technical Advisory Group on COVID-19 Vaccine Composition. Available from: https:\/\/www.who.int\/groups\/technical-advisory-group-on-covid-19-vaccine-composition-(tag-co-vac)"},{"key":"43836","unstructured":"Rosen A, Hartman M. What to know about JN.1, the latest omicron variant. Available from: https:\/\/publichealth.jhu.edu\/2024\/jn1-the-dominant-variant-in-the-covid-surge. Accessed on: 26\/12\/2023."},{"key":"43837","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7304a2"},{"key":"43838","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed on: 3\/03\/2024."},{"key":"43839","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.01.014"},{"key":"43840","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.1.2300703"},{"key":"43841","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae067"},{"key":"43842","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.10.2400109"}],"container-title":["Monaldi Archives for Chest Disease"],"original-title":[],"link":[{"URL":"https:\/\/www.monaldi-archives.org\/macd\/article\/download\/2981\/1922","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.monaldi-archives.org\/macd\/article\/download\/2981\/1922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:08:10Z","timestamp":1762934890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.monaldi-archives.org\/macd\/article\/view\/2981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.4081\/monaldi.2024.2981","relation":{},"ISSN":["2532-5264","1122-0643"],"issn-type":[{"type":"electronic","value":"2532-5264"},{"type":"print","value":"1122-0643"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}